Product Information
14488-1-AP targets MAGEA2 in WB, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag5889 Product name: Recombinant human MAGEA2 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-169 aa of BC063681 Sequence: MPLEQRSQHCKPEEGLEARGEALGLVGAQAPATEEQQTASSSSTLVEVTLGEVPAADSPSPPHSPQGASSFSTTINYTLWRQSDEGSSNQEEEGPRMFPDLESEFQAAISRKMVELVHFLLLKYQAREPVTKAEMLESVLRNCQDFFPVIFSKASEYLQLVFGIEVVEV Predict reactive species |
| Full Name | melanoma antigen family A, 2 |
| Calculated Molecular Weight | 35 kDa |
| GenBank Accession Number | BC063681 |
| Gene Symbol | MAGEA2 |
| Gene ID (NCBI) | 4101 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P43356 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Publications
What published studies show
The MAGEA2 Polyclonal antibody (Cat# 14488-1-AP) has 1 citation. It was used in a study published in Journal of Translational Medicine (2023), which investigated a multi-antigen targeted DNA vaccine for eliminating chemoresistant pancreatic cancer by disrupting tumor-stromal cell crosstalk. The antibody was applied in Western blot (WB) with human samples. The research falls within the fields of translational oncology and cancer immunotherapy.
| Species | Application | Title |
|---|---|---|
J Transl Med Immunization with a multi-antigen targeted DNA vaccine eliminates chemoresistant pancreatic cancer by disrupting tumor-stromal cell crosstalk |
